Joltoo
Investors
Grant catalog
Browse catalogFind your matchesFundersPrograms
FundraisingInsights
DeepTech 2026 PlaybookRequest access
Browse all
  1. Home
  2. /Investors
  3. /Synthetic Biology
  4. /Illumina Ventures
Illumina Ventures

Illumina Ventures

Pure DeepTechSan Diego, United StatesActiveWebsite
Stage FocusSeed, Series A, Series B+
GeographyUS
TypeCVC
Last Activity2025
Industry Focus
Industries
Synthetic BiologyBiotechMedtechAgritech
Technical BenchStrong
Investor TypeDeepTech Purist
ExposureMostly DeepTech Investments
Bio

Illumina Ventures is the CVC of Illumina, the dominant player in DNA sequencing, managing $560M+ in total AUM with Fund III targeting $200M (reduced from an initial $300M target). Across 51 investments, the portfolio includes foundational genomics companies: Twist Bioscience, CareDx, and Sherlock Biosciences, with 1 unicorn, 2 IPOs, and 12 acquisitions. Recent 2025 investments include Attovia Ther...

Notable Investments
T
Twist Bioscience
C
CareDx
S
Sherlock
A
Arima Genomics

Similar Funds

The Production Board

The Production Board

San Francisco, United States

Pure DeepTechSynthetic BiologyAgritechBiotechPre-SeedSeed
a16z Bio + Crypto (Andreessen Horowitz)

a16z Bio + Crypto (Andreessen Horowitz)

Menlo Park, United States

GeneralistSynthetic BiologyBlockchainBiotechSeedSeries A
Matū Group

Matū Group

Auckland, New Zealand

DeepTech NativeSynthetic BiologyAdvanced MaterialsMedtechPre-SeedSeed
Newpath Partners

Newpath Partners

Boston, United States

Pure DeepTechSynthetic BiologyBiotechMedtechSeedSeries A
SOSV

SOSV

New York, United States

Pure DeepTechSynthetic BiologyClimate TechRoboticsPre-SeedSeed
DCVC

DCVC

Palo Alto, United States

Pure DeepTechAIClimate TechBiotechSeedSeries A
Joltoo
SecurityPrivacy PolicyTerms of Service
© 2026 Joltoo. All rights reserved.